TNSN98175A1 - Implant contenant un parasiticide, et procede pour sa production - Google Patents
Implant contenant un parasiticide, et procede pour sa productionInfo
- Publication number
- TNSN98175A1 TNSN98175A1 TNTNSN98175A TNSN98175A TNSN98175A1 TN SN98175 A1 TNSN98175 A1 TN SN98175A1 TN TNSN98175 A TNTNSN98175 A TN TNSN98175A TN SN98175 A TNSN98175 A TN SN98175A TN SN98175 A1 TNSN98175 A1 TN SN98175A1
- Authority
- TN
- Tunisia
- Prior art keywords
- production
- implant
- parasiticide
- implant containing
- compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
L'INVENTION CONCERNE UN IMPLANT SOLIDE COMPRENANT AU MOINS UN COMPOSE PARASITICIDE A FAIBLE SOLUBILITE EN MILIEU ACQUEUX ET DES EXCIPIENTS DE COMPRESSION COMPRENANT UN DILUANT. ELLE CONCERNE EGALEMENT UN PROCEDE POUR LA PRODUCTION DE CET IMPLANT PAR MELANGE DU COMPOSE PARASITICIDE AUX EXCIPIENTS DE COMPRESSION ET MISE SOUS LA FORME DESIREE. APPLICATION :UTILISATION DE CET IMPLANT POUR PARVENIR A UNE PROTECTION PROLONGEE CONTRE DES PARASITES.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9720228.7A GB9720228D0 (en) | 1997-09-23 | 1997-09-23 | Parasiticidal formulations |
GBGB9810143.9A GB9810143D0 (en) | 1998-05-12 | 1998-05-12 | Parasiticidal formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN98175A1 true TNSN98175A1 (fr) | 2005-03-15 |
Family
ID=26312302
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNTNSN98175A TNSN98175A1 (fr) | 1997-09-23 | 1998-09-22 | Implant contenant un parasiticide, et procede pour sa production |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1014970A1 (fr) |
JP (1) | JP2001517622A (fr) |
AP (1) | AP9801350A0 (fr) |
AR (1) | AR013509A1 (fr) |
AU (1) | AU9742298A (fr) |
BR (1) | BR9812385A (fr) |
CA (1) | CA2304283A1 (fr) |
GT (1) | GT199800149A (fr) |
MA (1) | MA24655A1 (fr) |
PA (1) | PA8459501A1 (fr) |
PE (1) | PE117199A1 (fr) |
TN (1) | TNSN98175A1 (fr) |
WO (1) | WO1999015166A1 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPP279698A0 (en) * | 1998-04-03 | 1998-04-30 | Sunscape Developments Limited | Sustained release formulation |
US6645192B2 (en) | 1998-09-30 | 2003-11-11 | Ivy Animal Health, Inc. | Pellet implant system for immediate and delayed release of antiparasitic drug |
WO2001037811A1 (fr) * | 1999-11-22 | 2001-05-31 | Akzo Nobel N.V. | Compositions permettant de liberer un ingredient actif de façon predefinie et regulee, preparation et utilisation de ces compositions |
US6953586B1 (en) | 2000-06-08 | 2005-10-11 | Ivy Animal Health, Inc. | Growth promoting pharmaceutical implant |
DE10032878A1 (de) * | 2000-07-06 | 2002-01-17 | Bayer Ag | Anthelmintika zur Verhinderung von parasitären Infektionen bei Mensch und Tier |
AUPR602401A0 (en) | 2001-06-29 | 2001-07-26 | Smart Drug Systems Inc | Sustained release delivery system |
AUPR602501A0 (en) * | 2001-06-29 | 2001-07-26 | Smart Drug Systems Inc | Sustained release pharmaceutical composition |
AUPR610501A0 (en) * | 2001-07-04 | 2001-07-26 | Smart Drug Systems Inc | Treatment of parasitic disease |
US7918863B2 (en) | 2005-06-24 | 2011-04-05 | Conceptus, Inc. | Minimally invasive surgical stabilization devices and methods |
EP3634583A4 (fr) * | 2017-06-06 | 2021-03-03 | Merck Sharp & Dohme Corp. | Implant à action prolongée pour le traitement de maladies infectieuses |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0240274A3 (fr) * | 1986-04-03 | 1990-03-14 | Merck & Co. Inc. | Avermectine comme agents pour promotion de la croissance |
US4847243A (en) * | 1987-10-08 | 1989-07-11 | Merck & Co., Inc. | Treatment for fescue toxicosis in grazing animals |
NZ239370A (en) * | 1990-08-22 | 1994-04-27 | Merck & Co Inc | Bioerodible implantable controlled release dosage form comprising a poly(ortho ester) or a polyacetal with an active agent incorporated into the chain backbone |
US5411737A (en) * | 1991-10-15 | 1995-05-02 | Merck & Co., Inc. | Slow release syneresing polymeric drug delivery device |
-
1998
- 1998-09-04 BR BR9812385-8A patent/BR9812385A/pt not_active IP Right Cessation
- 1998-09-04 EP EP98951367A patent/EP1014970A1/fr not_active Withdrawn
- 1998-09-04 JP JP2000512535A patent/JP2001517622A/ja active Pending
- 1998-09-04 WO PCT/EP1998/005720 patent/WO1999015166A1/fr not_active Application Discontinuation
- 1998-09-04 CA CA002304283A patent/CA2304283A1/fr not_active Abandoned
- 1998-09-04 AU AU97422/98A patent/AU9742298A/en not_active Abandoned
- 1998-09-17 PA PA19988459501A patent/PA8459501A1/es unknown
- 1998-09-17 AP APAP/P/1998/001350A patent/AP9801350A0/en unknown
- 1998-09-21 AR ARP980104712A patent/AR013509A1/es unknown
- 1998-09-22 TN TNTNSN98175A patent/TNSN98175A1/fr unknown
- 1998-09-22 PE PE1998000903A patent/PE117199A1/es not_active Application Discontinuation
- 1998-09-22 MA MA25268A patent/MA24655A1/fr unknown
- 1998-09-22 GT GT199800149A patent/GT199800149A/es unknown
Also Published As
Publication number | Publication date |
---|---|
GT199800149A (es) | 2000-03-15 |
WO1999015166A1 (fr) | 1999-04-01 |
AP9801350A0 (en) | 2000-03-17 |
CA2304283A1 (fr) | 1999-04-01 |
EP1014970A1 (fr) | 2000-07-05 |
PA8459501A1 (es) | 2000-05-24 |
JP2001517622A (ja) | 2001-10-09 |
PE117199A1 (es) | 1999-11-20 |
AU9742298A (en) | 1999-04-12 |
BR9812385A (pt) | 2000-09-12 |
MA24655A1 (fr) | 1999-04-01 |
AR013509A1 (es) | 2000-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN98175A1 (fr) | Implant contenant un parasiticide, et procede pour sa production | |
HU9600299D0 (en) | Substituted azadioxacycloalkenes, fungicidal compositions containing them, process for the preparation of the compounds and the fungicidal compositions and method for combating fungi | |
PL348355A1 (en) | Fungicidal active substance combinations | |
AU5106996A (en) | Process for producing active agent preparations in the form of a solid solution of the active agent in a polymer matrix and active agent preparations obtained thereby | |
DZ2639A1 (fr) | Composés thérapeutiquement actifs basés sur le remplacement bio-isostérique du catéchol par l'indazole dans des inhibiteurs de PDE4 leur procédé de production et compositions pharmaceutiques les contenant. | |
AU6738696A (en) | Halobenzimidazoles and their use as microbicides | |
BR9909332A (pt) | Método & produto de tratamento de água | |
MY133996A (en) | Compounds for the treatment of ischemia | |
FR2764887B1 (fr) | Melange de diphenylamines nonylees, procede pour le preparer et composition le contenant | |
FR2780403B3 (fr) | Nouvelle forme de l'irbesartan, procedes pour obtenir ladite forme et compositions pharmaceutiques en contenant | |
NO970042D0 (no) | 2-£(Dihydro)pyrazolyl-3'-oksymetylen|-anilider, fremgangsmåte til fremstilling og anvendelse derav | |
AU699480B2 (en) | 2,2-Dichloroalkane carboxylic acids, processes for their production and pharmaceutical agents containing these | |
AU6200599A (en) | Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of acomposition for the treatment of ischemic stroke | |
ES2188011T3 (es) | Agente de contraste para la reproduccion en imagenes de infartos y necrosis. | |
MA27662A1 (fr) | Procede pour la fabrication d'une composition pharmaceutique sous la forme de comprimes contenant un fibrate et comprimes obtenus selon le procede | |
TNSN00106A1 (fr) | Composition pharmaceutique nouvelle comprenant un inhibiteur de nos, et procede pour sa preparation | |
DE69626657D1 (de) | Synergistische fungizide zusammensetzung, die eine strobilurin - ähnliche verbindung enthalt | |
EP1420066A3 (fr) | Utilisation de dérivé fullerene comme agent de compaction d'ADN | |
CA2296560A1 (fr) | Derives d'acides amines pour le traitement des accidents cerebrovasculaires | |
MA23194A1 (fr) | Procede pour la preparation de particules preparees a sec, particules preparees a sec ainsi obtenues et compositions pharmaceutiques contenant de telles particules . | |
TW360493B (en) | Fungicidal mixtures and a method of controlling fungi using the same | |
TW200501970A (en) | Use of PVP-iodine liposomes for treatment of acne | |
AU3031297A (en) | N-sulfonylimidazoles used as fungicides | |
MXPA04006040A (es) | Composicion con filtro solar que comprende clorfenesina. | |
WO2003044277A3 (fr) | Procede de desacidification de matieres a base de cellulose |